Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells

Journal of Biomedical Science

Volumn 13, Issue 1, 2006, Pages 143-156

  Lee, Chun Chung ^a,b   Chen, Shu Chen ^a,c   Tsai, Shiow Chwen ^a   Wang, Bao Wei ^a   Liu, Ya Chen ^a   Lee, Horng Mo ^c   Shyu, Kou Gi ^a,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AP 1; C jun; ERK; Hyperbaric oxygen; JNK; VEGF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; JANUS KINASE; JANUS KINASE INHIBITOR; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OXYGEN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; UMBILICAL VEIN; UPREGULATION;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, REPORTER; HUMANS; HYPERBARIC OXYGENATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 31544459246     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9037-7     Document Type: Article

References (40)

1. Thom S.R., Antagonism of carbon monoxide-mediated brain lipid peroxidation by hyperbaric oxygen. Toxicol. Appl. Pharmacol. 105: 340-344, 1990.
2. Hammarlund C. and Sunderberg T., Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast. Reconstr. Surg. 93: 829-833, 1994.
3. Uhl E., Sirsjo A., Haapaniemi T., Nilsson G. and Nylander G., Hyperbaric oxygen improves wound healing in normal and ischemic skin tissue. Plast. Reconstr. Surg. 93: 835-841, 1994.
4. Gill A.L. and Bell C.N.A., Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Q. J. Med. 97: 385-395, 2004.
5. Bartorelli A.L., Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction. Am. J. Cardiovasc. Drugs 3: 253-263, 2003.
6. LaVan F.B. and Hurt T.K., Oxygen and wound healing. Clin. Plastic Surg. 17: 421-432, 1990.
7. Ishii Y., Miyanaga Y., Shimojo H., Ushida T. and Tateishi T., Effect of hyperbaric oxygen on procollagen on messenger RNA level and collagen synthesis in the healing of rat tendon laceration. Tissue Eng. 5: 279-286, 1999.
8. Tompach P.C., Lew D. and Stoll J.L., Cell response to hyperbaric oxygen treatment. Int. J. Oral Maxillofac. Surg. 26: 82-86, 1997.
9. Piepmeier E.H. and Kalns J.E., Fibroblast response to rapid decompression and hyperbaric oxygenation. Aviat. Space Environ. Med. 70: 589-593, 1999.
10. Conconi M.T., Baiguera S., Guidolin D., Furlan C., Menti A.M., Vigolo S., Belloni A.S., Parnigotto P.P. and Nussdorfer G.G., Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J. Invest. Med. 51: 227-232, 2003.
11. Hollander D.A., Hakimi M.Y., Hartmann A., Wilhelm K. and Windolf J., The influence of hyperbaric oxygenation (HBO) on proliferation and differentiation of human keratinocyte cultures in vitro. Cell Tissue Bank 1: 261-269, 2000.
12. Meltzer T. and Myers B., The effect of hyperbaric oxygen on the bursting strength and rate of vascularization of skin wounds in the rat. Am. Surg. 52: 659-662, 1986.
13. Marx R.E., Ehler W.J., Tayapongsak P. and Pierce L.W., Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am. J. Surg. 160: 519-524, 1990.
14. Heng M.C., Harker J., Csathy G., Marshall C., Brazier J., Sumampong S. and Paterno Gomez E., Angiogenesis in necrotic ulcers treated with hyperbaric oxygen Ostomy. Wound Manage. 46: 18-28, 30-32, 2000.
15. Carmeliet P., Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6: 389-395, 2000.
16. Mustonen T. and Alitalo K., Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol. 129: 895-898, 1995.
17. Risau W., Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
18. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J. and Holash J., Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
19. Lin S., Shyu K.G., Lee C.C., Wang B.W., Chang C.C., Liu Y.C., Huang F.Y. and Chang H., Hyperbaric oxygen selectively induces angiopoietin-2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 296: 710-715, 2002.
20. Shi Q., Le X., Abbruzzese J.L., Peng Z., Qian C.N., Tang H., Xiong Q., Wang B., Li X.C. and Xie K., Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 61: 4143-4154, 2001.
21. Binetruy B., Smeal T. and Karin M., Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351: 122-127, 1991.
22. Smeal T., Binetruy B., Mercola D.A., Birrer M. and Karin M., Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354: 494-696, 1991.
23. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M. and Davis R.J., JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037, 1994.
24. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J. and Woodgett J.R., The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160, 1994.
25. Frost J.A., Geppert T.D., Cobb M.H. and Feramisco J.R., A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc. Natl. Acad. Sci. USA 91: 3844-3848, 1994.
26. Jaffe E.A., Nachman R.L., Becker C.G. and Minick C.R., Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745-2756, 1973.
27. Shyu K.G., Tsai S.C., Wang B.W., Liu Y.C. and Lee C.C., Saikosaponin C induces endothelial cells growth, migration and capillary tube formation. Life Sci. 76: 813-826, 2004.
28. Lin S., Huang H.C., Chen L.L., Lee C.C. and Huang T.S., GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription. Mol. Pharmacol. 60: 768-774, 2001.
29. Shyu K.G., Chang M.L., Wang B.W., Kuan P. and Chang H., Cyclical mechanical stretching increases the expression of vascular endothelial growth factors in rat vascular smooth muscle cells. J. Formos. Med. Assoc. 100: 741-747, 2001.
30. Hunt T.K. and Pai M.P., The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg. Gynecol. Obstet. 135: 561-567, 1972.
31. Knighton D.R., Silver I.A. and Hunt T.K., Regulation of wound healing angiogenesis-effect of oxygen gradients and spired oxygen concentration. Surgery 90: 262-270, 1981.
32. Sheikh A.Y., Gibson J.J., Rollins M.D., Hopf H.W., Hussain Z. and Hunt T.K., Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch. Surg. 135: 1293-1297, 2000.
33. Kang T.S., Gorti G.K., Quan S.Y., Ho M. and Koch R.J., Effect of hyperbaric oxygen on the growth factor profile of fibroblasts. Arch. Facial. Plast. Surg. 6: 31-35, 2004.
34. Cho M., Hunt T.K. and Hussain M.Z., Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am. J. Physiol. Heart Circ. Physiol. 280: H2357-2363, 2001.
35. Boguslawski G., McGlynn P.W., Harvey K.A. and Kovala A.T., SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro. J. Biol. Chem. 279: 5716-5724, 2004.
36. Wang B., Zou Y., Li H., Yan H., Pan J.S. and Yuan Z.L., Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1alpha in a mouse model of oxygen-induced retinopathy. J. Ocul. Pharmacol. Ther. Apr 21(2): 107-113, 2005.
37. Dulak J. and Jozkowicz A., Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid. Redox. Signal 5: 123-132, 2003.
38. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H. and Quon M.J., Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101: 1539-1545, 2000.
39. Angel P., Hattori K., Smeal T. and Karin M., The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875-885, 1988.
40. Halazonetis T.D., Georgopoulos K., Greenberg M.E. and Leder P., c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55: 917-924, 1988.